Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Evaluation of transcriptomic profiles of peripheral blood myeloid cell subsets of RA patients in remission prior to cDMARD withdrawal, and at the point of flare / 6 months after in sustained remission


ABSTRACT: To test the contribution of distinct ST-DC populations to either autoimmunity and inflammation or sustained disease remission, we evaluated the phenotypes of their blood precursors in a human model of disease flare following treatment withdrawal in RA patients in disease remission (the BioRRA study, (Baker et al., 2019)). We investigated the frequency and phenotype of PB DC2 and PB-DC3 of RA patients (n=12) in sustained clinical and ultrasound remission achieved with cDMARDs (Baker et al., 2019) by carrying out, and analysing single cell sequencing data at baseline remission levels, and upon endpoint after treatment withdrawal. We identified that PB DCs differ transcriptionally, but not proportionally, at the baseline of patients who sustain remission, versus those who go on to flare, and at endpoint. We propose that the transcriptomic profile of these peripheral blood DCs could be used as a biomarker of flare in remission RA patients.

INSTRUMENT(S): NextSeq 500

ORGANISM(S): Homo sapiens

SUBMITTER: Jack Frew 

PROVIDER: E-MTAB-14169 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2024-12-09 | E-MTAB-14191 | biostudies-arrayexpress
2020-04-18 | E-MTAB-8873 | biostudies-arrayexpress
2022-05-02 | E-MTAB-10430 | biostudies-arrayexpress
2023-12-21 | GSE245403 | GEO
2020-09-01 | E-MTAB-9451 | biostudies-arrayexpress
2023-05-31 | E-MTAB-12784 | biostudies-arrayexpress
2019-07-12 | GSE122612 | GEO
2024-02-27 | E-MTAB-13581 | biostudies-arrayexpress
2011-12-01 | E-GEOD-20872 | biostudies-arrayexpress
2020-05-20 | GSE140881 | GEO